News & Information

« Older Entries

Dr. Mark Sauer’s Response to Marcy Darnovsky’s New York Times Op-Ed, “Genetically Modified Babies”

New York Times

Research to Save Lives: A Response to “Genetically Modified Babies” by Marcy Darnovsky, Executive Director at the Center for Genetics and Society (Op-Ed, Feb. 25)

 

Every year, thousands of women give birth to children who will die as infants or young adults because of severe mitochondrial diseases. The procedure of mitochondrial transfer holds much promise of enabling these women to have healthy babies and removes the risk of disease in these children’s future offspring.

Dr. Mary D’Alton Weighs in on Brain Death and Pregnancy

Mary D'Alton, MD

Mary D’Alton, MD

New York Times op-ed columnist, Frank Bruni, examines a Texas law that compels hospitals to provide life support to brain-dead women who are pregnant.  He spoke with Dr. Mary D’Alton, Chair of the Department of Obstetrics & Gynecology at CUMC, who discussed the chances of the fetus surviving and the possible risks in fetal development.

Promising Ovarian Cancer Treatment Highlighted

Sharyn Lewin, MD

CBS News has reported on an experimental study of hyperthermic intraoperative chemotherapy (HIPEC), also known as heated chemotherapy, led by one of our gynecologic oncologists Dr. Sharyn Lewin. HIPEC has been previously used in treating other cancers, such as appendix and late stage color cancer. In this method, the chemotherapy is heated to approximately 108 degrees Fahrenheit, rather than standard room temperature.

Dr. Mary D’Alton Elected to the Institute of Medicine

Mary D'Alton, MD

Dr. Mary D’Alton, Chair of the Department of Obstetrics & Gynecology and Willard C. Rappleye Professor of Obstetrics & Gynecology at CUMC, has been elected to the Institute of Medicine (IOM). Considered one of the highest honors in the fields of health and medicine, the IOM recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

Dr. Ronald Wapner Supports New Prenatal Genetic Testing

Ronald Wapner, MD

The Washington Post recently examined innovations in prenatal genetic testing, including research on a new technique called chromosomal microarray analysis by NYP/CUMC reproductive geneticist Dr. Ronald Wapner. In an article published in the New England Journal of Medicine, microarray analysis was shown by Wapner and collaborators to be as effective as the standard method of amniocentesis analysis (karyotyping) in analyzing the number of chromosomes present in a fetal cell. In addition, the test found DNA abnormalities not detected in karyotyping.

Director of Human Resources and Faculty Affairs Profiled in CUMC Newsletter

Ester Quinn

Ester Quinn

Ester Quinn, director of human resources and faculty affairs in the Department of Obstetrics and Gynecology, is profiled in the latest CU168: News for and about the Columbia University Medical Center community newsletter. Quinn, an employee of the department for over 24 years, frequently travels the country with her husband on their Harley Davison motorcycle.

Dr. Cynthia Gyamfi-Bannerman Quoted on Delayed Umbilical Cord Clamping

Cynthia Gyamfi-Bannerman M.D.

Cynthia Gyamfi-Bannerman M.D.

The New York Times recently reported on a new study that found benefits to delaying the clamping and severing of the umbilical cord in newborns. Infants whose umbilical cords were not clamped until at least 1 minute after birth had higher hemoglobin levels and improved iron stores compared to those with early cord clamping, without any increased risk to the mother.

Dr. Sharyn Lewin Weighs in on Angelina Jolie’s Plans to Prevent Ovarian Cancer

Sharyn-Resize

Sharyn Lewin, M.D.

Actress and producer, Angelina Jolie reportedly plans to remove her ovaries after undergoing a preventative double mastectomy. New York Daily News spoke to Dr. Sharyn Lewin, a gynecological oncologist at NewYork-Presbyterian Hospital/Columbia University Medical Center, about taking such proactive measures and asked for her opinion.

« Older Entries